Gates Package — page 230

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl Bill & Melinda Gates Foundation (BMGF), Foundation for the National Institutes of Health, 2020-0601 Gift 12/3/2020] 12/31/2024} Inc. (FNIH) Paolo Lusso 2020-0607 CTA - Clinical Trial Agreement 5/1/2020} Emergent BioSolutions Inc. H Clifford Lane 2020-0663 CTA - Clinical Trial Agreement 5/21/2020 Grifols Shared Services North America, Inc. H Clifford Lane 2020-0664 CTA - Clinical Trial Agreement 5/1/2020] CSL Behring H Clifford Lane 2020-0666 CTA - Clinical Trial Agreement 5/5/2020} CSL Behring H Clifford Lane National Institute of Biomedical Imaging and Bioengineering (NIBIB/NIH), US Department of 2020-0685 Research Collaboration Agreement 7/2/2020] _7/18/2022|Defense (DoD) [US] Mathew Memoli Center for Advancing Innovation, Inc. [US], National 2020-0687 Letter of Intent/MOU 6/6/2020] 12/6/2021)Cancer Institute (NCI/NIH) Shirin Munir Center for Advancing Innovation, Inc. [US], National 2020-0687 Letter of Intent/MOU 6/6/2020} 12/6/2021}Cancer Institute (NCI/NIH) Shirin Munir Center for Advancing Innovation, Inc. [US], National 2020-0687 Letter of Intent/MOU 6/6/2020] 12/6/2021)Cancer Institute (NCI/NIH) Shirin Munir 2020-0692 Research Collaboration Agreement 5/14/2020] _5/14/2023]National Institute on Aging (NIA/NIH) Helen Su 2020-0692 Research Collaboration Agreement 5/14/2020] 5/14/2023] National Institute on Aging (NIA/NIH) Helen Su 2020-0713 Research Collaboration Agreement 6/4/2020] 6/4/2022] Calithera Biosciences, Inc. Ronald Germain 2020-0744 Gift 6/10/2021) 5/21/2024]Insmed Inc. [US] Steven Holland Excerpta Medica (funded by Sanofi), Genzyme (acq by Sanofi 2/16/2011) [US], Regeneron 2020-0837 Letter of Intent/MOU 7/20/2020) Pharmaceuticals, Inc. Amy Klion Chan Zuckerberg Initiative, Silicon Valley 2020-0879 Gift 9/8/2020} 8/31/2022|Community Foundation John Tsang 2020-0884 Research Collaboration Agreement 6/19/2020) 7/6/2025} Food and Drug Administration (FDA) Jeffery Taubenber 2020-0884 Research Collaboration Agreement 6/19/2020 7/6/2025] Food and Drug Administration (FDA) Jeffery Taubenber AstraZeneca Pharmaceuticals LP, National Cancer 2020-0886 CTA - Clinical Trial Agreement 6/16/2020) Institute (NCI/NIH) Michail Lionakis Yale University, Yale University School of Medicine 2020-0906 Research Collaboration Agreement 8/27/2020] 8/27/2022}[US] Yale University, Yale University School of Medicine 2020-0906 Research Collaboration Agreement 8/27/2020] 8/27/2022}[US]